Free standard shipping on orders $300+ · Same-day dispatch before 2PM AEST
AUSTRALIAN OWNED & OPERATED
FAST DISCREET SHIPPING AUSTRALIA WIDE
LAB TESTED FOR PURITY & QUALITY
Customer Support:
contact@aussiepeptideco.com
Batch-verified · ≥99.0% purity (HPLC) Batch ZL-09-10 · Tested by Janoshik Analytical · 17/06/2026
View COA
Growth Hormone Research

CJC-1295 With DAC 10mg

GHRH analogue with Drug Affinity Complex

Be the first to review SKU: APC-CJC-1295-WITH-DAC-10MG
Purity
≥99.0%
Lab Tested
Third-Party
Batch Specific
COA
$149.99 AUD
In Stock
Quantity
Order within for same-day dispatch
Secure CheckoutSSL Encrypted
Fast Australia WideDiscreet Shipping
Orders before 2pm AESTDispatched Same Day

Also searched as: CJC DAC, CJC-1295 DAC

Trusted Zynova Labs Supplier Genuine Zynova Labs research vials, stocked and dispatched from Melbourne.

Third-Party Tested

HPLC & mass spec verified purity

Batch Specific COA

Certificate with every batch

Discreet Packaging

Plain, unbranded, tamper-evident

Same-Day Dispatch

Before 2PM AEST, Australia-wide

CJC-1295 with DAC is a synthetic peptide supplied as a lyophilised research material for laboratory investigation. It is a modified analogue of growth hormone-releasing hormone (GHRH) and is primarily studied in relation to growth hormone signalling, endocrine pathways and the regulation of downstream insulin-like growth factor-1 (IGF-1). CJC-1295 with DAC products are intended strictly for controlled laboratory and scientific research. Batch-specific analytical documentation should be consulted to confirm the composition, purity and testing results of the individual material supplied.

What Is CJC-1295 with DAC?

CJC-1295 is a synthetic GHRH analogue designed to interact with the growth hormone-releasing hormone receptor (GHRHR). The peptide is of scientific interest because activation of this receptor is associated with signalling involved in growth hormone secretion.

The “DAC” refers to a Drug Affinity Complex, a structural modification designed to extend the peptide’s persistence by facilitating binding to circulating albumin. This distinguishes CJC-1295 with DAC from shorter-acting GHRH-related research peptides without the DAC modification.

Researchers therefore investigate CJC-1295 with DAC when studying prolonged GHRH-receptor signalling and associated endocrine mechanisms.

ManufacturerZynova Labs
Strength10mg
Molecular FormulaC165H269N47O46
Molecular Weight3647.3 g/mol
Purity≥99.0% (HPLC, batch ZL-09-10)
AppearanceWhite lyophilised powder
CAS No.863288-34-0
FormLyophilised Powder
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryGrowth Hormone Research
UsageFor Research Use Only. Not for human consumption.

Key Research Areas

CJC-1295 with DAC research has primarily examined:

These research areas should not be interpreted as established therapeutic benefits. Findings can vary considerably according to the experimental model and study design.

Why Researchers Study CJC-1295 with DAC

A major research characteristic of CJC-1295 with DAC is its structural modification. The DAC component allows researchers to examine how albumin binding can influence peptide persistence and biological signalling compared with shorter-duration GHRH analogues.

This makes the compound particularly relevant to experimental work examining the relationship between peptide structure, receptor activity and pharmacokinetic behaviour.

Research has also explored the downstream relationship between GHRH receptor activation, growth hormone signalling and IGF-1. These mechanisms remain distinct from claims that the research material produces specific clinical outcomes.

Key Research Areas at a Glance

GHRH receptor signalling and activation
Growth hormone secretion pathways
IGF-1-associated endocrine signalling
Pharmacokinetic behaviour of modified peptides
Albumin-binding mechanisms
Endocrine feedback and regulatory pathways
Experimental metabolic and body-composition mechanisms

CJC-1295 with DAC in Australia

Researchers looking for CJC-1295 with DAC in Australia should review the product specification, current stock status, listed price and available analytical documentation before ordering.

When comparing CJC-1295 with DAC online, particular attention should be given to batch identification and whether the supplier provides a corresponding CoA. Researchers should also confirm current Australian dispatch and shipping information directly from the supplier before placing an order.

This product is intended strictly for laboratory and in-vitro research purposes. It has not been evaluated for human or veterinary use, and any information provided here is for educational reference only.

Specifications

Product NameCJC-1295 With DAC 10mg
ManufacturerZynova Labs
Strength10mg
Molecular FormulaC165H269N47O46
Molecular Weight3647.3 g/mol
Purity≥99.0% (HPLC, batch ZL-09-10)
AppearanceWhite lyophilised powder
CAS No.863288-34-0
FormLyophilised Powder
VialSealed, sterile glass vial
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryGrowth Hormone Research
TestingIndependent third-party HPLC & MS
DocumentationBatch-specific COA included
UsageFor Research Use Only. Not for human consumption.

Certificate of Analysis

Quality, Purity and Batch Testing

CJC-1295 with DAC is typically supplied as a lyophilised laboratory material. Researchers should verify the exact vial quantity and analytical specification against the product’s batch documentation.

Where available, HPLC can provide information about analytical purity, while LC-MS or mass spectrometry may support molecular identity assessment. A batch-specific Certificate of Analysis (CoA) allows researchers to review results relating to the material supplied rather than relying solely on general product specifications.

Analytical purity should not be interpreted as evidence of clinical safety, suitability for human use or therapeutic effectiveness.

CERTIFICATE OF ANALYSIS
CJC-1295 With DAC 10mg
Batch: ZL-09-10 · 17/06/2026
Janoshik Analytical Certificate of Analysis for CJC-1295 With DAC 10mg

Storage & Handling

Storage and Laboratory Handling

  • Lyophilised Storage: Follow the verified storage conditions provided with the product or its batch documentation. Avoid assuming a storage temperature unless it has been confirmed for the supplied material.
  • After Reconstitution: Researchers should follow validated laboratory procedures and product-specific documentation. Where post-reconstitution stability has not been established, no unsupported storage period or temperature should be assumed.

Appropriate laboratory handling and documentation can help maintain sample traceability and experimental consistency.

Unopened VialStore at -20°C, protect from light & moisture
ReconstitutionBacteriostatic water (recommended)
After ReconstitutionRefrigerate at 2–8°C, use within 4 weeks
HandlingUse appropriate PPE and standard laboratory safety procedures
ShippingTracked, discreet delivery Australia-wide via Australia Post. Express available.

Reconstitution calculator: CJC-1295 With DAC 10mg

Work out concentration and the volume to draw for each aliquot before you add diluent.

mg
mL
Concentration
–
Volume per aliquot
–
On a 1 mL (U-100) syringe
–
Aliquots per vial
–

A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.

For Research Use Only. Not for human or veterinary consumption.

CJC-1295 With DAC 10mg: Frequently Asked Questions

It is a synthetic GHRH analogue incorporating a Drug Affinity Complex modification and supplied as a research material for laboratory investigation.

It is studied for its interaction with GHRH receptors and subsequent signalling associated with growth hormone and IGF-1 pathways.

DAC stands for Drug Affinity Complex. The modification is designed to facilitate albumin binding and extend peptide persistence.

Research has examined endocrine signalling, GHRH receptor activity, growth hormone pathways, IGF-1 signalling and peptide pharmacokinetics.

Researchers should check the specific product's batch documentation for its stated purity and analytical testing results.

Where supplied, a batch-specific CoA can provide analytical information associated with the individual production batch.

Follow the verified storage conditions accompanying the product and applicable laboratory protocols rather than assuming general stability conditions.

Availability depends on the supplier's current Australian stock and shipping arrangements. Researchers should verify the current price, batch documentation and dispatch information before ordering.

No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.

Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 With DAC 10mg”

Your email address will not be published. Required fields are marked *

Shopping Cart (0 items)

Your cart is empty

Add some research compounds to get started.

Browse Products